Neurology Minute podcast

The Amyloid Hypothesis for Alzheimer's disease and Aducanumab

0:00
1:57
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Dr. Erik Musiek discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer's disease.

Fler avsnitt från "Neurology Minute"